BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 123 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $234,546 | +2.1% | 33,128 | +1.6% | 0.00% | 0.0% |
Q2 2023 | $229,659 | +27.6% | 32,622 | +128.4% | 0.00% | 0.0% |
Q3 2022 | $180,000 | -42.9% | 14,285 | -53.8% | 0.00% | 0.0% |
Q1 2021 | $315,000 | -76.3% | 30,950 | -82.6% | 0.00% | -83.3% |
Q4 2020 | $1,329,000 | +198.7% | 178,325 | +37.7% | 0.01% | +200.0% |
Q3 2020 | $445,000 | +12.7% | 129,470 | +56.1% | 0.00% | 0.0% |
Q2 2020 | $395,000 | +66.0% | 82,955 | -30.4% | 0.00% | 0.0% |
Q1 2020 | $238,000 | -22.5% | 119,180 | +33.8% | 0.00% | 0.0% |
Q4 2019 | $307,000 | +132.6% | 89,050 | +253.8% | 0.00% | +100.0% |
Q3 2017 | $132,000 | +13.8% | 25,170 | +95.7% | 0.00% | 0.0% |
Q1 2015 | $116,000 | – | 12,860 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $44,153,847 | 52.00% |
ORACLE INVESTMENT MANAGEMENT INC | 585,194 | $6,718,027 | 5.60% |
Fairmount Funds Management LLC | 2,543,107 | $29,194,868 | 4.63% |
Saturn V Capital Management LP | 340,163 | $3,751,030 | 3.11% |
TANG CAPITAL MANAGEMENT LLC | 1,450,000 | $16,646,000 | 2.42% |
Avoro Capital Advisors LLC | 9,050,000 | $103,894,000 | 1.55% |
AlphaCentric Advisors LLC | 125,000 | $1,435,000 | 1.42% |
Sarissa Capital Management LP | 980,288 | $11,253,706 | 1.34% |
Ghost Tree Capital, LLC | 225,000 | $2,583,000 | 1.10% |
SILVERARC CAPITAL MANAGEMENT, LLC | 272,173 | $3,124,546 | 0.89% |